There were a couple of unanswered questions on this forum so I asked Fabian, who gave answers which he permitted me to share. The text conversation copied below.
Hi Fabian,Can you please tell me where the laboratory work will be done following Rana drilling? Also if we get to start drilling Penikat next winter is a deep drill to 1500m plus an option?
Hi Norm, we are just finalising the assay route, it looks like we will be working with ALS Laboratories, we ship to a preparation lab in Sweden who prepare a smaller sample and then send to ALS in Ireland who do the analysis. Turnaround time is generally good from them at 4-6 weeks. There is an alternative route with another firm also via prep in Sweden then analysis in Canada but we are waiting for a commitment on turnaround times before considering that as don't want to be caught amongst busy sample flow from the Canadian summer work programs.
At Penikat we wouldn't rush to drill quite so deep as 1,500m, the initial aim is to demonstrate continuity to 500m vertical below surface which is about 700-750m down dip given the angle of the ore body. That is the depth to which we took the Exploration Target and is a reasonable depth that a deposit can be mined more economically via a decline rather than a shaft (higher CAPEX and OPEX) based on advice we recieved from mining engineers. Given the potential scale of Penikat, we can fit more than enough ounces to that depth, remember the Exploration Target only considered 2 of the 3 reefs due to a lack of data on the AP Reef, but that one also hosts the ballroom feature and has been mapped at surfact over 8km of strike on our ground. Ultimately we will drill deeper holes, but not in year 1.
- Forums
- ASX - By Stock
- Kingrose Mining - Banter and General Discussion
KRM
kingsrose mining limited
Add to My Watchlist
1.61%
!
3.1¢

There were a couple of unanswered questions on this forum so I...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.1¢ |
Change
-0.001(1.61%) |
Mkt cap ! $22.98M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 3.0¢ | $2.92K | 97.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 306039 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 633333 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 306039 | 0.030 |
5 | 772874 | 0.029 |
2 | 20071 | 0.028 |
3 | 1240370 | 0.027 |
1 | 125000 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 633333 | 2 |
0.033 | 1361720 | 5 |
0.034 | 254000 | 2 |
0.035 | 304970 | 3 |
0.037 | 100000 | 2 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
KRM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online